HomeBUSINESS
BUSINESS

Pfizer, Takeda to End Xeljanz Distribution/Copromotion Scheme
(Dec.19.2017)

Pfizer Japan and Takeda Pharmaceutical said on December 18 that they will wind up their distribution/copromotion arrangement for the rheumatoid arthritis (RA) treatment Xeljanz (tofacitinib citrate) at the end of March 2018 ...
(LOG IN FOR FULL STORY)

News Calendar